138 related articles for article (PubMed ID: 28769012)
1. In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil.
Higashi H; Watanabe N; Tamura R; Taguchi M
Biol Pharm Bull; 2017; 40(8):1314-1319. PubMed ID: 28769012
[TBL] [Abstract][Full Text] [Related]
2. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
[TBL] [Abstract][Full Text] [Related]
3. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.
Ito T; Yano I; Tanaka K; Inui KI
J Pharmacol Exp Ther; 1997 Aug; 282(2):955-60. PubMed ID: 9262363
[TBL] [Abstract][Full Text] [Related]
4. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein.
Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
Jpn J Cancer Res; 2000 Feb; 91(2):248-54. PubMed ID: 10761713
[TBL] [Abstract][Full Text] [Related]
5. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.
Tahara K; Kagawa Y; Takaai M; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2008; 23(5):340-6. PubMed ID: 18974611
[TBL] [Abstract][Full Text] [Related]
6. Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK.
Endo T; Kimura O; Sakata M
Toxicol Appl Pharmacol; 2002 Dec; 185(3):166-71. PubMed ID: 12498733
[TBL] [Abstract][Full Text] [Related]
7. Effects of P-glycoprotein inhibitors on transepithelial transport of cadmium in cultured renal epithelial cells, LLC-PK1 and LLC-GA5-COL 150.
Kimura O; Endo T; Hotta Y; Sakata M
Toxicology; 2005 Mar; 208(1):123-32. PubMed ID: 15664439
[TBL] [Abstract][Full Text] [Related]
8. Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function.
Patanasethanont D; Nagai J; Yumoto R; Murakami T; Sutthanut K; Sripanidkulchai BO; Yenjai C; Takano M
J Pharm Sci; 2007 Jan; 96(1):223-33. PubMed ID: 17031860
[TBL] [Abstract][Full Text] [Related]
9. The possible clinical impact of risperidone on P-glycoprotein-mediated transport of tacrolimus: A case report and in vitro study.
Watanabe N; Higashi H; Nakamura S; Nomura K; Adachi Y; Taguchi M
Biopharm Drug Dispos; 2018 Jan; 39(1):30-37. PubMed ID: 29055041
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene.
Tanaka K; Hirai M; Tanigawara Y; Ueda K; Takano M; Hori R; Inui K
Biochem Pharmacol; 1997 Mar; 53(5):741-6. PubMed ID: 9113094
[TBL] [Abstract][Full Text] [Related]
11. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil.
Choi MK; Song IS
J Pharm Pharmacol; 2012 Aug; 64(8):1074-83. PubMed ID: 22775210
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction of green tea beverage containing cyclodextrins and high concentration catechins with P-glycoprotein substrates in LLC-GA5-COL150 cells in vitro and in the small intestine of rats in vivo.
Oda K; Murakami T
J Pharm Pharmacol; 2017 Dec; 69(12):1736-1744. PubMed ID: 28980319
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein.
Morishita H; Okawa K; Ishii M; Mizoi K; Ito MA; Arakawa H; Yano K; Ogihara T
PLoS One; 2020; 15(10):e0232438. PubMed ID: 33119612
[TBL] [Abstract][Full Text] [Related]
14. Is MIBG a substrate of P-glycoprotein?
Kiyono Y; Yamashita T; Doi H; Kuge Y; Katsura T; Inui K; Saji H
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):448-52. PubMed ID: 17096097
[TBL] [Abstract][Full Text] [Related]
15. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
[TBL] [Abstract][Full Text] [Related]
16. Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells.
Weiss J; Theile D; Spalwisz A; Burhenne J; Riedel KD; Haefeli WE
Biochem Pharmacol; 2013 Jan; 85(2):265-73. PubMed ID: 23219525
[TBL] [Abstract][Full Text] [Related]
17. Interaction of digoxin with antihypertensive drugs via MDR1.
Takara K; Kakumoto M; Tanigawara Y; Funakoshi J; Sakaeda T; Okumura K
Life Sci; 2002 Feb; 70(13):1491-500. PubMed ID: 11895100
[TBL] [Abstract][Full Text] [Related]
18. Outward transfer of dopamine precursor L-3,4-dihydroxyphenylalanine (L-dopa) by native and human P-glycoprotein in LLC-PK(1) and LLC-GA5 col300 renal cells.
Soares-Da-Silva P; Serrão MP
J Pharmacol Exp Ther; 2000 May; 293(2):697-704. PubMed ID: 10773046
[TBL] [Abstract][Full Text] [Related]
19. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
